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Background: Recent laboratory studies employing an extended sleep deprivation model have mapped
sleep-related changes in behavior onto functional alterations in specific brain regions supporting emotion,
suggesting possible biological mechanisms for an association between sleep difficulties and deficits in emotion
regulation. However, it is not yet known if similar behavioral and neural changes are associated with the more
modest variability in sleep observed in daily life.
Methods: We examined relationships between sleep and neural circuitry of emotion using the Pittsburgh Sleep
Quality Index and fMRI data from a widely used emotion regulation task focusing on cognitive reappraisal of
negative emotional stimuli in an unselected sample of 97 adult volunteers (48 women; mean age 42.78±7.37 years,
range 30–54 years old).
Results: Emotion regulation was associated with greater activation in clusters located in the dorsomedial prefrontal
cortex (dmPFC), left dorsolateral prefrontal cortex (dlPFC), and inferior parietal cortex. Only one subscale from the
Pittsburgh Sleep Quality Index, use of sleep medications, was related to BOLD responses in the dmPFC and dlPFC
during cognitive reappraisal. Use of sleep medications predicted lesser BOLD responses during reappraisal, but
other aspects of sleep, including sleep duration and subjective sleep quality, were not related to neural activation in
this paradigm.
Conclusions: The relatively modest variability in sleep that is common in the general community is unlikely to
cause significant disruption in neural circuits supporting reactivity or regulation by cognitive reappraisal of negative
emotion. Use of sleep medication however, may influence emotion regulation circuitry, but additional studies are
necessary to determine if such use plays a causal role in altering emotional responses.
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Sleep problems are highly comorbid with psychiatric dis-
orders [1,2] and have been found to predict the onset of
both depressive episodes [3] and mania [4]. Although
available data suggest a causal link between sleep and
psychiatric symptoms, a compelling biological mechan-
ism has not yet been reported. One hypothesis is that
poor sleep compromises neural systems supporting emo-
tion regulation [5]. Although this hypothesis was first
based on clinical experience and anecdote, it has more* Correspondence: jared.minkel@duke.edu
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reproduction in any medium, provided the orrecently been supported by independent lines of re-
search that have established key neural and behavioral
correlates of sleep deprivation in controlled laboratory
experiments [6,7].
In general, these experiments have identified the pre-
frontal cortex, which plays a key role in the cognitive
control of emotion [8], as particularly sensitive to sleep
loss [9]. Experimental sleep deprivation studies have
reported subjective [10], physiological [11], and neural
[7] changes consistent with exaggerated responsiveness
to negative emotional stimuli. The strongest support for
this position comes from a study reporting decreased
functional connectivity between the medial prefrontal
cortex (mPFC) and amygdala in sleep deprived subjectsLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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photographs [7]. Although this emotion elicitation para-
digm did not directly assess emotion regulation, the
pathway involved shares considerable overlap with ca-
nonical emotion regulation circuitry [12], indicating that
sleep deprivation results in deficient capacity to regulate
strong emotional arousal. However, a serious limitation
of studies to date is that they have used experimental
paradigms with relatively long periods of sustained
wakefulness that are very rare in real world settings.
In the present study, we extend the literature on the
influence of sleep on neural substrates of emotion in
three important ways. First, a well-characterized emotion
regulation paradigm was administered during BOLD
fMRI. This paradigm allows for the robust engagement
of neural circuits, including the amygdala and mPFC,
involved in emotional reactivity as well as cognitive re-
appraisal [13]. Cognitive reappraisal may be a particu-
larly important process because it is one of the primary
ways people can voluntarily alter their own emotional
experiences [14] and is believed to represent a psycho-
logical mechanism by which people with psychiatric dis-
orders improve mood and prevent relapse during
cognitive behavior therapy [15,16]. To our knowledge,
this is the first study to investigate relationships between
sleep and emotion regulation per se. Second, self-
reported sleep variables were collected using a widely
utilized measure [17], allowing for the mapping of rela-
tionships between neural function associated with emo-
tional regulation and individual differences in sleep
variables commonly encountered in real-world settings.
Third, our relatively large (N = 97), community-based
sample allows greater generalizability than previous
studies that have used smaller samples (less than 30), ex-
treme levels of sleep deprivation rarely encountered in
real-world settings, and young adult samples. Based on
the existing literature, we hypothesized that sleep pro-
blems, particularly short sleep-duration, would predict
deficits in neural activation supporting emotion regula-
tion. Specifically, we predicted sleep problems would be
associated with greater amygdala activation in response
to negative emotional stimuli and lower activation in the
mPFC during regulation of negative emotional stimuli.
Methods
Participants
Participants were recruited from Phase II of the Adult
Health and Behavior project (AHAB II), which assesses a
wide range of behavioral and biological traits among
middle-aged community volunteers. All participants had
completed both the emotion regulation fMRI task and the
Pittsburgh Sleep Quality Index (PSQI) and were in good
general health. The University of Pittsburgh Institutional
Review Board approved the study and all participantsprovided informed consent in accordance with its regula-
tions. Participants were evaluated for current DSM-IV
Axis I disorders using the Mini-International Neuro-
psychiatric Interview (MINI [18]) and excluded only for
history of psychosis. The participants were free of medical
diagnoses of cancer, stroke, diabetes requiring insulin
treatment, and chronic kidney or liver disease. Additional
exclusion criteria included use of psychotropic, gluco-
corticoid, hypolipidemic, antiarrhythmic, antihypertensive,
and prescription weight loss medication. Sleep medica-
tions were allowed if they were not taken more than 7 of
14 days prior to eligibility determination.
Our initial sample included 106 unselected participants,
but 8 were removed for amygdala coverage less than 90%.
One additional participant was removed for abnormally
high motion artifact, leaving a final sample of 97 partici-
pants (48 women; mean age 42.78 ± 7.37 years, range 30–
54 years old).
Measures
Pittsburgh Sleep Quality Index (PSQI)
All participants completed the PSQI, a 19-item self-rated
questionnaire for evaluating general sleep patterns over the
previous month [17]. The questionnaire is scored to pro-
duce seven clinically-derived component scores, each of
which is converted to a 0–3 scale where higher numbers
indicate more problematic sleep. Many of the component
scores are based on a single item or reflect a single calcula-
tion based on two or more items. The component scores
are subjective sleep quality, sleep latency, sleep duration,
habitual sleep efficiency (a measure of time spent asleep to
total time spent in bed), sleep disturbances, use of sleeping
medication, and daytime dysfunction. The combined score
is reported as Global Sleep Quality. Global scores greater
than 5 indicate clinically meaningful sleep disturbance.
Center for Epidemiologic Studies Depression Scale (CES-D)
To ensure that observed relationships were not better
accounted for by co-occurring symptoms of mood disor-
ders, depression symptoms were also evaluated using the
CES-D [19]. The CES-D is a 20-item measure of depres-
sion symptoms that has been evaluated and used in
many studies of psychiatric symptoms and disorders. A
cutoff score of 16 has been used to differentiate those
who are likely to have clinically meaningful levels of de-
pressive symptoms from those who are not [20].
Emotion regulation paradigm
The emotion regulation task in this experiment was
adapted from a previously validated paradigm [8,13].
The task consisted of 30 negative photographs and 15
neutral photographs selected from the International
Affective Picture System (IAPS) database based on pub-
lished norms [21]. Negative photographs depicted bodily
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photographs), members of hate groups (2 photographs),
transportation accidents (2 photographs) and human
waste (2 photographs). Neutral photographs depicted in-
animate objects (10 photographs) or neutral scenes (5
photographs).
Prior to completing the task, subjects were instructed
that when cued to “look,” they were to maintain atten-
tion on the stimulus and allow their emotional reaction
to occur without attempting to change it. When cued to
“decrease,” they were to attempt to reduce their emo-
tional response through cognitive reappraisal (i.e., by
thinking of something that makes the photograph seem
less negative). Subjects were given examples of re-
appraisal strategies for specific photographs and then
practiced the skill outside the MRI scanner. During the
MRI scan each trial consisted of a 2 second cue to either
“look” or “decrease” one’s emotional response, then a
7 second presentation of either a negative or neutral pic-
ture, then a 4 second opportunity to rate the picture, fol-
lowed by a 1–3 second rest period before the next cue.
During the “rate picture” phase, subjects were instructed
to report their emotional reaction to each photograph
on a scale of 1 to 5, where 1 indicated neutral and 5
indicated feeling strongly negative. The ratings were
made using a button response pad in the participant’s
right hand and recorded in E-Prime software.
Fifteen negative photographs were presented with the
“look” cue and 15 were presented with the “decrease”
cue. All 15 neutral photographs were presented with the
“look” cue (because there is nothing to regulate in re-
sponse to a neutral photograph). The stimuli were pre-
sented in pseudo-random order such that no more than
2 of the same instruction (look vs. regulate) could be
presented consecutively and no more than 4 negative
stimuli could be presented consecutively. Total time for
the task was 11:28 minutes. This design allows for an as-
sessment of neural activation related to the emotional
valence of the stimuli (look negative > look neutral) as
well as activation related to reappraisal (regulate nega-
tive > look negative).
BOLD fMRI data acquisition
Each participant was scanned using a Siemens 3 T Alle-
gra scanner (Siemens AG, Medical Solutions, Erlangen,
Germany) developed specifically for advanced brain im-
aging applications and characterized by increased T2*
sensitivity and fast gradients that minimize echo spacing,
thereby reducing echo-planar imaging (EPI) geometric
distortions and improving image quality. An autoshim-
ming procedure was conducted to minimize field inho-
mogeneities. A series of 34 interleaved axial slices
aligned with the AC-PC plane were acquired with a
gradient-echo echo planar imaging sequence (TR/TE =2000 ms/25 ms; FOV = 200 mm, matrix size 64 × 64;
3.125 × 3.125 × 3 mm voxels; interslice skip = 0). Two
initial RF excitations were performed (and discarded) to
achieve steady-state equilibrium. However, the first two
acquired volumes were discarded during preprocessing
to further ensure steady-state equilibrium. All scanning
parameters were selected to optimize the quality of the
BOLD signal while maintaining a sufficient number of
slices to acquire whole brain data. Before the collection
of fMRI data for each participant, we acquired a refer-
ence EPI scan that we visually inspected for artifacts
(e.g., ghosting) as well as good signal across the entire vol-
ume of acquisition.
BOLD fMRI data analysis
Whole-brain image analysis of all fMRI data was
conducted at the Laboratory of NeuroGenetics at
Duke University using the general linear model
(GLM) of SPM8 (http://www.fil.ion.ucl.ac.uk/spm).
Images for each participant were realigned to the
first volume in the time series to correct for head
motion, spatially normalized into a standard stereo-
tactic space (Montreal Neurological Institute tem-
plate) using a 12-parameter affine model (final
resolution of functional images = 2 mm isotropic vox-
els), and smoothed to minimize noise and residual
difference in gyral anatomy with a Gaussian filter,
set at 6-mm full-width at half-maximum. Prepro-
cessed data sets were analyzed using second-level
random-effects models that account for both scan-
to-scan and participant-to-participant variability to
determine task-specific regional responses.
Variability in single-subject whole-brain functional
volumes was determined using the Artifact Recognition
Toolbox (http://www.nitrc.org/projects/artifact_detect).
Individual whole-brain BOLD fMRI volumes meeting at
least one of the following two criteria were identified as
artifacts during the determination of task-specific effects:
1) significant mean-volume signal intensity variation 2
(i.e., within volume mean signal greater or less than 4
standard deviations of mean signal of all volumes in time
series), and 2) individual volumes where scan-to-scan
movement exceeded 2 mm translation or 2° rotation in
any direction. Artifacts were then treated as regressors of
no interest in subsequent preprocessing steps. One par-
ticipant was removed from further analyses due to abnor-
mally high artifact (37% of whole-brain BOLD fMRI
volumes). The remaining participants had, on average,
2.64% of all volumes identified as artifacts, thus we be-
lieve this approach enhanced our capacity to determine
task-specific effects by minimizing the influence of
volumes with substantial variability without compromis-
ing our power to detect task-specific effects by excluding
a large number of volumes.
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canonical hemodynamic response functions were used
to estimate condition-specific (i.e. negative > neutral and
regulate > look) BOLD responses for each individual. In-
dividual contrast images (i.e., weighted sum of the beta
images) were then used in second-level random effects
models accounting for scan-to-scan and participant-to-
participant variability to determine mean condition-
specific regional responses using one-sample t-tests. A
voxel-level statistical threshold of p < 0.05, FWE cor-
rected for multiple comparisons (across the anatomical
amygdala ROIs for negative > neutral, and across whole
brain for regulate > look) was applied. An additional ex-
tent threshold of 10 contiguous voxels was applied to
both ROI and whole brain analyses.
Based on previous findings [7,13,22] we selected the
amygdala as a region of interest (ROI) where we
expected to find effects of emotional reactivity (negative
> neutral contrast). A bilateral amygdala ROI mask was
created from the Automated Anatomical Labeling (AAL)
atlas [23]. Because of the potential for signal loss and
noise often observed in the amygdala and adjacent
regions, single-subject BOLD fMRI data were included
in subsequent analyses only if there was a minimum of
90% signal coverage in the amygdala masks bilaterally.
Although we anticipated finding main effects of task in
regions previously identified [8,13], these analyses were
completed using whole brain analyses. No additional
ROI masks were created.
BOLD parameter estimates from clusters exhibiting
condition-effects (negative > neutral; regulate > look) were
extracted using the VOI tool in SPM8 and exported for
analyses in R and SPSS (v.18). Extracting parameter esti-
mates from functional clusters activated by our fMRI
paradigm, rather than clusters specifically correlated with
our independent variables of interest, precludes the possi-
bility of any correlation coefficient inflation that may
result when an explanatory covariate is used to select
a region of interest [24]. We have used this more
conservative and rigorous analytic strategy in recent
studies [25,26].
Statistical analyses
The influence of sleep duration on emotional reactivity
and emotion regulation was investigated using regres-
sion analyses. Because sleep duration was measured
prior to the emotion regulation task and because it is
believed to play a causal role in influencing subjective
responses and neural responses during emotional re-
activity and regulation, it was treated as an independent
variable in all regression analyses. Dependent variables
included subjective emotional responses to photographs
as well as extracted BOLD parameter estimates from
max voxels of clusters showing significant condition-effects and ratings of emotional reactions during each
condition. Dependent variables were analyzed to ensure
they were approximately normally distributed prior to
entry into regression analyses. Relationships among
subjective emotional reactions and extracted BOLD par-
ameter estimates were investigated using Pearson corre-
lations. Because we made a priori predictions that
poorer sleep would predict less brain activation during
emotion regulation and less subjective regulatory suc-
cess, one-tailed significance tests were used in these ana-
lyses. For all other analyses, two-tailed significance tests
were used.
Results
Negative emotion induction and regulation
manipulation checks
Emotional reactivity
Subjective responses to photographs were compared
using paired samples t-tests. Two subjects were excluded
based on abnormal or missing self-report data. These
analyses confirmed that negative photographs elicited
significantly greater negative emotion than neutral
photographs (t(95) = 37.02, p < .001).
Based on previous findings [7,22], we focused our
analyses of neural responses associated with emotional
reactivity (negative > neutral contrast) on amygdala acti-
vation. A significant condition-effect was found in both
the left (89 voxels, t =5.73, p < .001; -20, -6, -14) and
right (39 voxels, t =4.70, p < .001; 20, -4, -16) amygdala
(Figure 1).
Emotion regulation
Cognitive reappraisal was associated with significantly
less intense subjective negative emotion than simply
viewing negative photographs (t(95) = 9.65, p < .001).
These results confirmed that the emotion regulation
paradigm produced the intended subjective effects and
that participants were able to regulate their emotional
responses through reappraisal.
Analyses of neural responses associated with cognitive
reappraisal (regulate > look contrast) revealed significant
main effects of task in three clusters located within the
medial prefrontal cortex (mPFC), left dorsolateral pre-
frontal cortex (dlPFC), and inferior parietal cortex (IPC,
Figure 2). Regulatory success (computed as the dif-
ference between subjective responses in the regulate
negative and look negative conditions) was significant-
ly correlated with activation in the mPFC (r = .206,
p = .044) and IPC (r = .213, p = .037) and trended toward
a significant relationship with activation in the left dlPFC
cluster (r = .184, p = .073), indicating that greater activa-
tion in these clusters was associated with more effective
use of reappraisal, as indexed by lower overall subjective
emotional responses to the negative stimuli.
Figure 1 Statistical parametric map illustrating amygdala
activation associated with viewing IAPS photographs (look
negative > look neutral). Maximal voxel MNI coordinates for left
amygdala activation: -20, -6, -14; 89 voxels, t=5.73, p<.001. Maximal
voxel MNI coordinates for right amygdala activation: 20, -4, 16; 39
voxels, t=5.00, p<.001.
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Sleep and emotional reactivity
Sleep was measured using the Pittsburgh Sleep Quality
Index (see Table 1 for frequency and severity of sleep
problems). Global Sleep Quality, i.e., the composite score
reflecting the sum of all subscales) was analyzed to de-
termine overall relationships among sleep and emotional
reactivity (see Table 1 for PSQI score descriptive
statistics). Global Sleep Quality scores did not predictFigure 2 Statistical parametric map illustrating whole brain activation a
photographs (regulate negative > look negative). The cluster in the dors
significant relationship with regulatory success based on subjective respon
for medial prefrontal cluster: 0, 10, 60; 241 voxels, t=6.32, p<.001. The cluste
coordinates for dlPFC cluster: -42, 8, 52; 198 voxels, t=7.11, p<.001, showed
p=.07). A third cluster (not visible here) was located in the inferior parietal
t=6.98, p<.001.left (b = −.135, p = .19) or right (b = −.044, p = .67) amyg-
dala activation during the negative > neutral contrast.
Global PSQI scores were also unrelated to subjective
responses to negative vs. neutral photographs (b = −.134,
p = .193). Neither sleep duration nor sleep quality pre-
dicted left (ps > .59) or right (ps > .41) amygdala activation
in the negative > neutral contrast. Similarly, there was no
relationship between PSQI subscales and subjective emo-
tional responses to negative vs. neutral photographs in the
“look” condition (ps > .29), except for a trend toward
poorer subjective sleep quality predicting less intense sub-
jective emotional responses (b = −.189, p = .066).
Sleep and emotion regulation
Global PSQI scores predicted activation in the mPFC
cluster, (b = −.190, p = .03) such that worse sleep was
associated with less mPFC activity (Figure 3). Global
PSQI scores were not significantly related to activation
in the dlPFC cluster (b = −.052, p = .31) or the IPC clus-
ter (r = .003, p = .49). Similarly, Global PSQI scores were
not significantly related to self-reported regulatory suc-
cess (r = .008, p = .47). Analyses of PSQI subscales
revealed a significant relationship between use of sleep
medication and activation in the mPFC cluster (b = −.23,
p = .02), left dlPFC cluster (b = −.22, p = .02) and IPC
cluster (b = −.196, p = .03). Use of sleep medication
did not predict self-reported regulatory success however
(b = 0.017, p = .44). Use of sleep medication was relatively
rare with 12 subjects (6 women) reporting such use in the
last month. Of these, 7 reported using sleep medication
less than once per week and 5 reported using sleep medi-
cations 1–2 times per week. Due to these small groups,
they were combined and compared to those who did not
use sleep medications (n = 85, 42 women). Independent
samples t-tests confirmed that those who used sleepssociated with reappraisal of emotional responses to negative IAPS
al medial prefrontal cortex (mPFC; within the red circle) showed a
ses to IAPS photographs (r=.21, p=.04). Maximal voxel MNI coordinates
r in the left dorsolateral prefrontal cortex (dlPFC), maximal voxel MNI
a marginally significant relationship with regulatory success (r=.18,
cortex and had maximal voxel MNI coordinates -50, -58, 46; 481 voxels,
Table 1 Pittsburgh Sleep Quality Index Component Scores
Frequency (N=97)
Subscale M (SD) Normal 0 Mild 1 Moderate 2 Severe 3
Subjective Sleep Quality .94 (.67) 24 56 16 1
Sleep Latency .85 (.73) 31 53 10 3
Sleep Duration .87 (.64) 26 59 11 1
Habitual Sleep Efficiency .30 (.64) 76 14 6 1
Sleep Disturbances 1.31 (.53) 1 67 27 2
Use of Sleeping Medication .18 (.50) 85 7 5 0
Daytime Dysfunction .71 (.56) 33 59 5 0
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cluster (t(23.1) = 3.85, p < .001) and dlPFC cluster (t(23.2)
= 3.17, p = .002) than those who did not use sleep medica-
tions, but differences in activation in the IPC cluster
showed a non-significant trend (t(95) = 1.56, p = .06;
Figure 4). All other PSQI subscales failed to predict activa-
tion in the dlPFC cluster (all b < .12, ps > .26), mPFC clus-
ter (all b < .11, ps > .16), or IPC cluster (all b < .10, ps
> .20). Furthermore, controlling for all other PSQI sub-
scales had no effect on relationships between use of sleep
medications and neural activation supporting emotion
regulation (mPFC cluster: b = −.20, p = .04, dlPFC: b =
−.24, p = .02, IPC cluster: b = −.24, p = .02). Removing par-
ticipants who reported using sleep medication from the
analyses resulted in a non-significant relationship0.4
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Figure 3 Scatter plot showing individual differences in activation in
negative > look negative contrast based on global sleep quality sc
activation (b = -.190, p = .03). Filled circles indicate participants who repobetween Global Sleep Quality and activation in
the mPFC (b = −0.75, p = .50).
One final analysis we conducted was to create a com-
posite score of all PSQI subscales except medication use.
Here we included all participants, including those who
reported using sleep medication, but did not allow this
medication use to affect their Global PSQI score. The
relationship between mPFC activation and this compos-
ite sleep score was nearly significant (b = 0.16, p = .06)
suggesting that it may have not been the use of sleep
medication per se that accounted for this relationship.
Control analyses
Additional analyses were completed in order to ensure
that our findings related to sleep and emotion were not8 10 12 14 16
p Quality (PSQI)
the medial prefrontal cortex (mPFC) for the regulate
ores for the PSQI. Worse sleep predicted less mPFC cluster
rted using sleep medication within the last month.
Figure 4 Activation during the regulate negative > look
negative condition was greater for those who denied use of
sleep medication in the last 30 days (dark gray bars, n = 85)
than for those who endorsed it (light gray bars, n = 12).
Differences were significant in the medial prefrontal cluster (mPFC,
p = .001) and left dorsolateral prefrontal cluster (dlPFC, p = .004) and
there was a non-significant trend in the inferior parietal cortex
cluster (IPC, p = .06).
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symptoms, measured by the CES-D, were highly corre-
lated with PSQI Global scores (r = .56, p < .001), but
were not significantly correlated with activation in the
clusters identified above (ps > .20). Similarly, subjects
scoring above the CES-D cutoff score of 16 (n = 14) did
not show significantly different activation relative to
those scoring below the cutoff score in any of the clus-
ters identified above (ps > .62). There was a non-
significant trend toward greater depression symptoms
predicting less self-reported regulatory success (b =
−.177, p = 0.09).
Discussion
Inadequate sleep is thought to produce exaggerated
emotional responses by compromising the top-down in-
hibitory control of the prefrontal cortex over amygdala
driven emotional arousal [5-7]. If true, this could be a
promising mechanism that contributes to relatively high
rates of depression in industrialized and developing
nations. Our findings suggest however, that findings
from experimental settings, where wakefulness can be
extended for long durations, were not replicated in our
sample where more modest variability in sleep was
observed. Because this was a large, unselected sample
from the community, we believe the findings are more
relevant for public policy than smaller self-selected sam-
ples typical of experimental studies. Although there was
a significant relationship between the composite PSQIscore Global Sleep Quality and neural activation in the
mPFC, analyses of subscales showed that most aspects
of sleep were unrelated to emotional functioning. Per-
haps most important was the finding that there were no
significant relationships between emotional responses to
negative photographs and either how much participants
slept (sleep duration) or their reports of how well they
slept (subjective sleep quality). We interpret these find-
ings as evidence that the human nervous system can
preserve regulatory efficiency of negative emotion within
the variability in sleep observed in the general popula-
tion. Because our paradigm measured emotional reactiv-
ity with and without voluntary regulation strategies, we
believe these findings are particularly robust. It is im-
portant to emphasize, however, that these findings can-
not necessarily be extended to clinical populations.
There is substantial evidence that relationships between
sleep and emotion may be very different in people with
psychiatric diagnoses such as Bipolar Disorder and
Major Depression [4,27] and additional investigations of
underlying biological mechanisms to explain those dif-
ferences are needed. One final caveat is that in an unse-
lected sample, people are free to choose their own sleep
schedule and those who are most sensitive to sleep loss
may choose to sleep more than those who are more re-
silient. The emotional consequences of sleep loss may be
more profound in subgroups that cannot choose their
own sleep schedules, such as emergency personnel and
shift workers. Additional studies are needed to investi-
gate possible emotional consequences of abnormal sleep
in these populations.
Our secondary analyses suggested that the relationship
between the composite PSQI score Global Sleep Quality
and neural activation during cognitive reappraisal was
primarily driven by the PSQI subscale related to sleep
medications. Use of sleep medication was associated
with reduced activation in both the dorsolateral pre-
frontal and medial prefrontal clusters. This finding, if
replicated, would suggest that sleep medication should
be used with caution, especially in people with a predis-
position for mood problems. We would like to
emphasize, however, that this was an unexpected finding
from a correlational study that cannot establish a causal
relationship between sleep medication use and the ab-
normalities identified. In addition, data were not avail-
able on the class of sleep medications these participants
used, so additional studies are needed to investigate
what influence, if any, different classes of sleep medica-
tion have on emotion regulation circuitry. It is also pos-
sible that a third variable can explain both sleep
medication use and abnormal neural responses during
the emotion regulation task. Perhaps the most likely
such variable, namely depressive symptoms, was ruled
out by our analyses. There was no relationship between
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in this community sample. Future studies could extend
these findings considerably by evaluating emotion regu-
lation before and after the administration of sleep medi-
cations. Because the participants who used sleep
medication also reported greater sleep disturbances
overall, it is further possible that this relationship
more generally reflects a negative impact of moderate
to severe sleep disturbance on the engagement of pre-
frontal regions during cognitive reappraisal of emotional
stimuli.
The analyses reported above have several important
limitations we would like to emphasize. First, we esti-
mated average sleep duration using self-report, where
objective methods such as actigraphy or polysomnogra-
phy would have been more accurate, suggesting that we
may have failed to detect a true correlation. Our rela-
tively large sample size partially attenuates this concern,
but future studies might be able to detect small, but sta-
tistically significant effects through actigraphy or poly-
somnography. Second, our sample consisted of adults in
the age range of 30 to 54 years. There is reason to be-
lieve that sleep may have different effects on emotion
throughout the lifespan [5,10] and additional studies of
different age groups are needed to better understand
these relationships in children, adolescents, and the eld-
erly. Finally, although depression symptoms were mea-
sured and could therefore be evaluated as possible
confounds, there were many other potential confounds,
such as stress or anxiety, that we could not evaluate in
this study.
Conclusions
We believe that the analyses presented above demon-
strated two important findings. First, they suggest that
healthy normal adults can cope with mild to moderate
sleep problems without showing large changes in neural
or subjective emotional functioning, at least in response
to passive experiences of negative stimuli. Nevertheless,
only a handful of studies have investigated the neurobio-
logical bases of emotional changes associated with sleep
and more research is needed to understand main effects
and individual differences in affective responses to sleep
loss. Second, we found evidence suggesting that taking
sleep medications may result in altered neural function
supporting emotion regulation, and that these alterations
may more broadly reflect the negative impact of moder-
ate to severe sleep disturbances. Although preliminary,
we believe this finding justifies additional studies
designed to evaluate the impact of sleep medications on
emotion regulation.
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